The androgen receptor (AR) is involved in the differentiation and growth of many endocrine cancers, including breast cancer, prostate cancer, ovarian cancer, endometrial cancer, bladder cancer, thyroid cancer [1–9]. Here, AR is linked to ovarian carcinoma.